OP2E:XETRA:XETRA-Ossiam Lux Ossiam MSCI EMU NR (EUR)

ETF | Others |

Last Closing

USD 150.26

Change

+0.46 (+0.31)%

Market Cap

N/A

Volume

1.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.08 (+0.17%)

USD 502.95B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.02 (+0.14%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.05 (+0.18%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.21%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.07 (+0.27%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.24 (-0.89%)

USD 102.11B
JARI:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.05%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.08 (+0.16%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+4.10 (+0.77%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.04 (+0.15%)

USD 79.79B

ETFs Containing OP2E:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.18% 58% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.18% 57% F 58% F
Trailing 12 Months  
Capital Gain 12.07% 53% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.07% 53% F 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.03% 51% F 51% F
Dividend Return 5.03% 51% F 49% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.39% 76% C+ 81% B-
Risk Adjusted Return 78.81% 84% B 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike